We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Artificial Pancreas Guidance Retains Flexibility, Focus on Human Factors
Artificial Pancreas Guidance Retains Flexibility, Focus on Human Factors
November 9, 2012
Companies developing artificial pancreas device systems for type 1 diabetes should demonstrate that the device is safe for layperson use and address such real-world concerns as mobility and water exposure, an FDA final guidance says.